There is a large and compelling body of clinical evidence showing that, for many cancers, proton therapy is overall safer and more effective than conventional radiation, particularly for complex and difficult-to-treat tumors.
And yet, many insurance companies still deny coverage. This is a key reason the New York Proton Center invests so heavily in proton therapy research.
The New York Proton Center has developed a one-of-a-kind research program that aims to further the evidence supporting proton therapy and, in doing so, to make this potentially lifesaving treatment more widely available to patients.
